Drug Type Synthetic peptide |
Synonyms- |
Target |
Action inhibitors |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Discovery | Canada | - | |
Glaucoma | Discovery | Canada | - | |
Neoplasms | Discovery | Canada | - |